|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M80.80XA |
Other osteoporosis with current pathological fracture, unspecified site, initial encounter for fracture
In the inpatient setting, there should generally be very limited and rare
circumstances for which the laterality (right, left, bilateral) of a condition is unable to be
documented and reported.
|
M8080XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 45.65%
|
18.23%
|
10.74%
|
7.25%
|
5.62%
|
3.79%
|
1.92%
|
2.32%
|
0.84%
|
0.84%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M80.80XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
328
|
328
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
310
|
344
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
270
|
270
|
|
82306
|
VITAMIN D 25 HYDROXY |
233
|
234
|
|
J0897
|
DENOSUMAB INJECTION |
227
|
13,680
|
|
97110
|
THERAPEUTIC EXERCISES |
179
|
263
|
|
80053
|
COMPREHEN METABOLIC PANEL |
178
|
178
|
|
77080
|
DXA BONE DENSITY AXIAL |
154
|
154
|
|
83970
|
ASSAY OF PARATHORMONE |
145
|
145
|
|
97530
|
THERAPEUTIC ACTIVITIES |
131
|
147
|
|
J3111
|
INJ. ROMOSOZUMAB-AQQG 1 MG |
108
|
21,216
|
|
84443
|
ASSAY THYROID STIM HORMONE |
95
|
95
|
|
84100
|
ASSAY OF PHOSPHORUS |
81
|
81
|
|
J3489
|
ZOLEDRONIC ACID 1MG |
81
|
399
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
77
|
80
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
76
|
76
|
|
80048
|
METABOLIC PANEL TOTAL CA |
74
|
74
|
|
82310
|
ASSAY OF CALCIUM |
70
|
71
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
68
|
68
|
|
97116
|
GAIT TRAINING THERAPY |
62
|
62
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M80.80XA related to the following DRG Codes:
542-544
791
793
|
